ALPA vs INDSWFTLAB: Stock Comparison

Alpa Laboratories Limited vs Ind-Swift Laboratories Limited

Live data: 22 July 2026, 2:55 PM IST • Source: NSE and company filings

Ind-Swift Laboratories Limited is the larger company by market capitalisation. Alpa Laboratories Limited shows a lower P/E, a higher ROE and faster revenue growth, while Ind-Swift Laboratories Limited shows a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Alpa Laboratories Limited and Ind-Swift Laboratories Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ALPA is more favourable on 8 of 13 scored metrics and INDSWFTLAB on 3These counts are context-free and are not an overall rating.

Key Differences

Market Cap
INDSWFTLAB is the larger company
₹2,035 Cr vs ₹142 Cr
P/E Ratio
ALPA has a lower P/E
12.09x vs 50.25x
P/B Ratio
ALPA has a lower P/B
0.77x vs 1.5x
EPS
ALPA has higher earnings per share
₹7.14 vs ₹4.84
Revenue Growth (TTM YoY)
ALPA has faster revenue growth
-21.4% vs -66.6%
EPS Growth (TTM YoY)
ALPA has faster EPS growth
0% vs -94.8%
Qtr Sales Growth
INDSWFTLAB has stronger quarterly sales growth
22.8% vs -21.3%
Qtr Profit Growth
ALPA has stronger quarterly profit growth
165% vs 9.35%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricALPAINDSWFTLAB
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricALPAINDSWFTLAB
Live Price₹66.98₹234.31
Day Change-0.98%-1.38%
Volume6,9583.77 L
52-Week High₹105.51₹248.45
52-Week Low₹46.1₹87.15
Distance from 52W High-36.52%-5.69%

Valuation

MetricALPAINDSWFTLAB
Market Cap₹142 Cr₹2,035 Cr
P/E Ratio12.09x50.25x
P/B Ratio0.77x1.5x
EPS₹7.14₹4.84
Book Value₹32.34₹165.77
Dividend Yield0%0%

Growth

MetricALPAINDSWFTLAB
Revenue Growth (TTM YoY)-21.4%-66.6%
EPS Growth (TTM YoY)0%-94.8%
Qtr Sales Growth-21.3%22.8%
Qtr Profit Growth165%9.35%

Profitability & Leverage

MetricALPAINDSWFTLAB
ROE8.39%3.87%
ROCE9.42%4.7%
Net Margin14.33%41.4%
Operating Margin3.11%7.03%
Debt to Equity0.01x0.01x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricALPAINDSWFTLAB
Promoter Holding57.19%42.99% 3.49 pp
FII Holding0.35% 0.03 pp13.88% 0.45 pp
DII Holding0.07% 0.07 pp0% 0.68 pp
Public Holding42.39% 0.04 pp43.12% 2.38 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Alpa Laboratories Limited and Ind-Swift Laboratories Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.